Despite appropriate antiepileptic drug treatment, approximately one-third of humans and
dogs with epilepsy continue experiencing seizures, emphasising the importance for new
treatment strategies to improve the quality of life of people or dogs with epilepsy. A
6-month prospective, randomised, double-blinded, placebo-controlled cross-over dietary
trial was designed to compare a ketogenic medium-chain TAG diet (MCTD) with a standardised
placebo diet in chronically antiepileptic drug-treated dogs with idiopathic epilepsy. Dogs
were fed either MCTD or placebo diet for 3 months followed by a subsequent respective
switch of diet for a further 3 months. Seizure frequency, clinical and laboratory data
were collected and evaluated for twenty-one dogs completing the study. Seizure frequency
was significantly lower when dogs were fed the MCTD (2·31/month, 0–9·89/month) in
comparison with the placebo diet (2·67/month, 0·33–22·92/month, P=0·020);
three dogs achieved seizure freedom, seven additional dogs had ≥50 % reduction in seizure
frequency, five had an overall <50 % reduction in seizures (38·87 %, 35·68–43·27 %)
and six showed no response. Seizure day frequency were also significantly lower when dogs
were fed the MCTD (1·63/month, 0–7·58/month) in comparison with the placebo diet
(1·69/month, 0·33–13·82/month, P=0·022). Consumption of the MCTD also
resulted in significant elevation of blood β-hydroxybutyrate
concentrations in comparison with placebo diet (0·041 (sd 0·004)
v. 0·031 (sd 0·016) mmol/l, P=0·028). There
were no significant changes in serum concentrations of glucose (P=0·903),
phenobarbital (P=0·422), potassium bromide (P=0·404) and
weight (P=0·300) between diet groups. In conclusion, the data show
antiepileptic properties associated with ketogenic diets and provide evidence for the
efficacy of the MCTD used in this study as a therapeutic option for epilepsy
treatment.
Background: Adult dogs with neosporosis can develop a variety of neurologic signs. No area of predilection within the nervous system so far has been identified in adult dogs.
Objectives: To document neosporosis as a cause of progressive cerebellar ataxia and cerebellar atrophy in dogs.
Animals: Seven client‐owned dogs.
Methods: Retrospective, descriptive study.
Results: Age at diagnosis ranged from 1 year 6 months to 9 years 11 months. Neuroanatomic localization indicated cerebellar and brainstem disease in 6 dogs and a central vestibular lesion in 1 dog. In all 7 dogs, there was moderate to marked bilaterally symmetrical cerebellar atrophy, with the atrophied cerebellum being surrounded by a region of T2‐weighted hyperintense and T1‐weighted hypointense signal. Cerebrospinal fluid (CSF) analysis in all but 1 dog showed mononuclear pleocytosis and high protein concentration. Polymerase chain reaction testing for Neospora caninum performed on the CSF was positive in 4/5 dogs tested and there was a high titer of serum antibodies to N. caninum (≥ 1 : 800) in all 6 dogs tested. Postmortem examination in 1 dog confirmed cerebellar atrophy and multifocal nonsuppurative encephalitis with areas of malacia and leptomeningitis. All of the remaining 6 dogs were treated with some combination of clindamycin, trimethoprim, sulfadiazine, and pyrimethamine. Two dogs were euthanized because of deterioration or relapse of neurologic signs, but treatment of the remaining 4 dogs resulted in improvement (3 dogs) or resolution (1 dog) of neurologic signs.
Conclusions and Clinical importance: Neosporosis is an important cause of progressive cerebellar ataxia and cerebellar atrophy in adult dogs.
Raised IL-6 but not CRP predicted cognitive decline in this population Inflammatory changes associated with cognitive decline may be specific to particular causal pathways.
This study investigated the cross sectional area (CSA) and fat infiltration of the epaxial muscles in Dachshunds with compressive spinal cord lesions due to intervertebral disc herniation (IVDH) and in dogs with non-compressive spinal cord lesions with fibrocartilaginous embolism (FCE). The CSA and fat infiltration of the multifidi and longissimus dorsi muscles were determined from T1 weighted magnetic resonance images. Difference in CSA and fat infiltration between the lesion- and non-lesion side in the Dachshunds was assessed using mixed model analysis. Difference in CSA and fat infiltration between Dachshunds and FCE dogs was analysed with independent sample t-tests. There was no difference in CSA or fat infiltration between sides in the Dachshunds. FCE dogs had greater CSA (multifidus P = 0.036, longissimus P < 0.001) and less fat infiltration compared to Dachshunds (longissimus P = 0.017). Duration of neurological deficits, age, body size and conformation are likely to have influenced the difference between the groups.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.